Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 26Neoplasm Metastasis 7Neoplasms 5Squamous Cell Carcinoma of Head and Neck 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Breast Neoplasms 2Brain Neoplasms 2Advanced Solid Tumors 2Thyroid Neoplasms 1Recurrence Free Survival 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Lung Neoplasms 1Inflammatory Breast Neoplasms 1Histiocytosis 1Glioma 1Fallopian Tube Neoplasms 1Erythema 1Endometrial Neoplasms 1Edema 1Dihydropyrimidine Dehydrogenase Deficiency 1Colorectal Cancer Metastatic 1Cholangiocarcinoma 1

Interventions

Paclitaxel 7Cyclophosphamide 6Doxorubicin 5pembrolizumab 3Trastuzumab 3Taxes 3Specimen Handling 3Carboplatin 3pertuzumab 2eribulin 2Radiotherapy 2Epirubicin 2Docetaxel 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1ruxolitinib 1pegfilgrastim 1onvansertib 1olaparib 1neratinib 1durvalumab 1cobimetinib 1atezolizumab 1X-Rays 1Therapeutics 1Tamoxifen 1Surgical Procedures, Operative 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Panitumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammatory Breast Neoplasms × Panitumumab × 1 year × Clear all
NCT02876107 2026-04-15

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
42 enrolled
Breast

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡